Testosterone is an ally of macrophages in the battle against adrenal cancers

byCNRSMacrophages attacking adrenal tumor in male mouse. Credit: © Julie Olabe CNRS/GReDWhy are cancers of the adrenal glands more common among women? Why are prognoses worse for them? A team of

Updated on: December 22,2023

Testosterone is an ally of macrophages in the battle against adrenal cancers

byCNRSMacrophages attacking adrenal tumor in male mouse. Credit: © Julie Olabe CNRS/GReDWhy are cancers of the adrenal glands more common among women? Why are prognoses worse for them? A team of

Updated on:December 22,2023

Increased risk of prostate cancer in men with BRCA2 gene fault

by Cancer Research UKCredit: CC0 Public DomainMen with the BRCA2 gene fault have an increased risk of prostate cancer and could benefit from PSA (prostate specific antigen) testing to help detect

Updated on: May 09,2024

Increased risk of prostate cancer in men with BRCA2 gene fault

by Cancer Research UKCredit: CC0 Public DomainMen with the BRCA2 gene fault have an increased risk of prostate cancer and could benefit from PSA (prostate specific antigen) testing to help detect

Updated on:May 09,2024

A bad influence—the interplay between tumor cells and immune cells

by Huntsman Cancer InstituteCells live in complex communities called microenvironments, where many different types of cells interact with one another. In cancer, the microenvironment is a place where

Updated on: December 18,2023

A bad influence—the interplay between tumor cells and immune cells

by Huntsman Cancer InstituteCells live in complex communities called microenvironments, where many different types of cells interact with one another. In cancer, the microenvironment is a place where

Updated on:December 18,2023

Evaluation of ruxolitinib, a JAK inhibitor, in multiple myeloma

by Impact Journals LLCRuxolitinib exerts its anti-myeloma effects through several mechanisms. Credit:Oncotarget(2024). DOI: 10.18632/oncotarget.28547A new research perspective titled &quot

Updated on: May 07,2024

Evaluation of ruxolitinib, a JAK inhibitor, in multiple myeloma

by Impact Journals LLCRuxolitinib exerts its anti-myeloma effects through several mechanisms. Credit:Oncotarget(2024). DOI: 10.18632/oncotarget.28547A new research perspective titled &quot

Updated on:May 07,2024

Building trust and saving lives: A community approach to genetic education

by Medical University of South CarolinaCatilin Allen, Ph.D., of MUSC Hollings Cancer Center. Credit: Medical University of South Carolina, Sarah Pack.Changes to DNA, known as mutations, can incre

Updated on: June 17,2024

Building trust and saving lives: A community approach to genetic education

by Medical University of South CarolinaCatilin Allen, Ph.D., of MUSC Hollings Cancer Center. Credit: Medical University of South Carolina, Sarah Pack.Changes to DNA, known as mutations, can incre

Updated on:June 17,2024

Negative fecal tests tied to low risk for advanced colorectal cancer

by Lori SolomonThere was a low risk for advanced neoplasia after multiple rounds of negative fecal immunochemical tests (FIT) in people undergoing surveillance colonoscopy, according to a study publis

Updated on: June 22,2024

Negative fecal tests tied to low risk for advanced colorectal cancer

by Lori SolomonThere was a low risk for advanced neoplasia after multiple rounds of negative fecal immunochemical tests (FIT) in people undergoing surveillance colonoscopy, according to a study publis

Updated on:June 22,2024

Study highlights the importance of infection prevention after CAR T-cell therapy

Study highlights the importance of infection prevention after CAR T-cell therapybyDana-Farber Cancer InstituteDistribution of causes of nonrelapse deaths across treatment settings and disease en

Updated on: July 09,2024

Study highlights the importance of infection prevention after CAR T-cell therapy

Study highlights the importance of infection prevention after CAR T-cell therapybyDana-Farber Cancer InstituteDistribution of causes of nonrelapse deaths across treatment settings and disease en

Updated on:July 09,2024

Time for a 'Weed-Free January?' How cannabis users could benefit from a 'dry' month

by James MacKillop,The ConversationCredit: RDNE Stock project from PexelsBy now, most are familiar with the idea of Dry January, a voluntary month without alcohol that follows a month when many

Updated on: March 26,2024

Time for a 'Weed-Free January?' How cannabis users could benefit from a 'dry' month

by James MacKillop,The ConversationCredit: RDNE Stock project from PexelsBy now, most are familiar with the idea of Dry January, a voluntary month without alcohol that follows a month when many

Updated on:March 26,2024

New hormone therapies before surgery may improve outcomes in high-risk prostate cancer

byWolters Kluwer HealthTime to BCR in the neo-RP and RP cohorts after IPTW. The number of participants at risk are based on unweighted population. Credit:Journal of Urology(2022). DO

Updated on: January 04,2024

New hormone therapies before surgery may improve outcomes in high-risk prostate cancer

byWolters Kluwer HealthTime to BCR in the neo-RP and RP cohorts after IPTW. The number of participants at risk are based on unweighted population. Credit:Journal of Urology(2022). DO

Updated on:January 04,2024

Identification of colony stimulating factor 1 receptor offers new strategy for cancer immunotherapy

by Zhang Nannan,Chinese Academy of SciencesIHMT-CSF1R-833 alters the macrophage polarization in M2 macrophages derived from RAW264.7 cells by inducing the M1 macrophage phenotype. Credit: Liang

Updated on: December 25,2023

Identification of colony stimulating factor 1 receptor offers new strategy for cancer immunotherapy

by Zhang Nannan,Chinese Academy of SciencesIHMT-CSF1R-833 alters the macrophage polarization in M2 macrophages derived from RAW264.7 cells by inducing the M1 macrophage phenotype. Credit: Liang

Updated on:December 25,2023

Management of refractory or relapsed classic Hodgkin lymphoma in Brazil

by Impact Journals LLCHodgkin lymphoma, nodular lymphocyte predominant (high-power view) Credit: Gabriel Caponetti, MD./Wikipedia/CC BY-SA 3.0Anew review papertitled "Current perspect

Updated on: December 28,2023

Management of refractory or relapsed classic Hodgkin lymphoma in Brazil

by Impact Journals LLCHodgkin lymphoma, nodular lymphocyte predominant (high-power view) Credit: Gabriel Caponetti, MD./Wikipedia/CC BY-SA 3.0Anew review papertitled "Current perspect

Updated on:December 28,2023

Clinical trial examines standard vs. extended lymph node removal for muscle-invasive bladder cancer

by SWOG Cancer Research NetworkCredit: Pixabay/CC0 Public DomainFinal results from the SWOG S1011 randomized Phase III clinical trial, published in theNew England Journal of Medicine, indicate p

Updated on: November 10,2024

Clinical trial examines standard vs. extended lymph node removal for muscle-invasive bladder cancer

by SWOG Cancer Research NetworkCredit: Pixabay/CC0 Public DomainFinal results from the SWOG S1011 randomized Phase III clinical trial, published in theNew England Journal of Medicine, indicate p

Updated on:November 10,2024